Patents by Inventor Peter LaFayette

Peter LaFayette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260265768
    Abstract: Predictable and reliable gene stacking will simplify the breeding process, saving time and resources. The Cre-Lox recombination system offers the ability to easily add, remove, or alter traits for more precise control over plant characteristics. The system uses specific bespoke loxP sites to ensure unidirectional gene insertion, creating a “Loxbox” to prevent further insertions at the same site. This method allows for iterative, targeted gene stacking approach to user-defined genetic engineering by recombination in a plant cell, plant tissue, plant material, plant part, and/or plant with predictable directionality. By creating a toolkit for targeted sequential gene insertion, the trait development pipeline can be streamlined, making it easier and faster to develop new plant varieties with desirable traits.
    Type: Application
    Filed: March 4, 2026
    Publication date: September 10, 2026
    Inventors: Katie Toomey, Peter LaFayette, Wayne Parrott
  • Patent number: 7005561
    Abstract: Disclosed herein are novel methods and materials for selecting transgenic cells. Specifically exemplified herein are positive selection methods that involve conferring to cells the ability to metabolize certain compounds, preferably arabitol, ribitol, raffinose, sucrose, mannitol or combinations thereof. Accordingly, transformed cells can be selected by simply subjecting them to a medium containing such compounds. The subject invention alleviates the disadvantages and concerns of negative selection methods, such as the unnecessary killing of transformed cells and the dispersal of potentially harmful genes (e.g., antibiotic or herbicide resistant genes) into the environment. Furthermore, novel nucleotide sequences relating to the E. coli rtl operon and arabitol dehydrogenase gene, and amino acid sequences relating to the gene products thereof are disclosed.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: February 28, 2006
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Wayne Parrott, Peter LaFayette, Patrick Kane
  • Publication number: 20030041352
    Abstract: Disclosed herein are novel methods and materials for selecting transgenic cells. Specifically exemplified herein are positive selection methods that involve conferring to cells the ability to metabolize certain compounds, preferably arabitol, ribitol, raffinose, sucrose, mannitol or combinations thereof. Accordingly, transformed cells can be selected by simply subjecting them to a medium containing such compounds. The subject invention alleviates the disadvantages and concerns of negative selection methods, such as the unnecessary killing of transformed cells and the dispersal of potentially harmful genes (e.g., antibiotic or herbicide resistant genes) into the environment. Furthermore, novel nucleotide sequences relating to the E. coli rtl operon and arabitol dehydrogenase gene, and amino acid sequences relating to the gene products thereof are disclosed.
    Type: Application
    Filed: March 8, 2001
    Publication date: February 27, 2003
    Inventors: Wayne Parrott, Peter LaFayette, Patrick Kane